Cystinuria is an inherited kidney disorder that causes excessive cystine excretion and recurrent kidney stone formation. The global prevalence is approximately 1 in 7,000 people, making it the most common genetic cause of kidney stones in children. Men may experience more severe presentations than women.
While kidney stones remain the primary manifestation, 20-25 percent of affected individuals may develop chronic kidney disease. Early diagnosis and consistent treatment can help prevent complications and preserve kidney function.
What Is Cystinuria?
Cystinuria occurs when the body cannot properly reabsorb cystine and other amino acids in the kidney’s filtering system. Under normal circumstances, the kidneys filter these amino acids from the blood and then reabsorb most of them back into circulation. However, genetic defects disrupt this process, allowing excessive cystine to remain in the urine.
Cystine has extremely limited solubility in urine at normal pH, making it prone to crystallization when its concentration rises. These crystals can grow into stones that may block the urinary tract and cause severe pain.
The condition results from mutations in genes that produce proteins responsible for amino acid transport. Type A involves mutations in the SLC3A1 gene, while Type B involves mutations in the SLC7A9 gene.
Symptoms of Cystinuria
Recurrent kidney stones represent the sole clinical feature of cystinuria. Most symptoms begin during the first two decades of life, with 80 percent of affected individuals experiencing their initial stone before age 20. Males typically have more frequent and severe episodes throughout their lives.
Sharp, severe pain in the lower back or side of the abdomen marks the typical presentation. This pain, known as renal colic, often radiates toward the groin area and may come in intense waves as stones move through the urinary system. The discomfort can be excruciating and may require emergency medical attention for adequate pain control.
Blood in the urine frequently accompanies stone episodes, ranging from microscopic traces detectable only through laboratory testing to noticeable red or pink discoloration that causes immediate concern. Additional symptoms during active episodes include burning during urination, nausea, vomiting, and frequent urges to urinate.
Many people experience complete wellness between stone formation periods, though recurrent urinary tract infections may develop when stones cause blockages or create areas where bacteria can accumulate and multiply.
Types and Stages of Cystinuria
Medical classification depends on the specific genetic mutations involved. Type A results from mutations affecting both copies of the SLC3A1 gene, while Type B involves mutations in the SLC7A9 gene. A rare mixed variant, Type AB, occasionally occurs when individuals have mutations in both genes.
Stone formation patterns vary considerably among affected individuals. Some people consistently form pure cystine stones, while others form mixed stones containing calcium oxalate or phosphate. Large staghorn stones that branch throughout the kidney collecting systems can form in severe cases.
The frequency and severity of episodes vary widely, even among family members with identical mutations. Environmental factors, dietary habits, and fluid intake patterns all influence clinical expression.
Causes and Risk Factors
Inherited gene mutations cause all cases of cystinuria, and there is no established link between genetics and presentation. Type A follows autosomal recessive inheritance, meaning both parents must carry altered genes for a child to be affected. Type B inheritance appears more complex, sometimes displaying dominant patterns with incomplete expression.
Family history represents the most substantial risk factor. Parents and siblings of individuals with a diagnosis should consider screening. Genetic counseling can provide\ valuable guidance for affected families.
Notable geographic and ethnic variations in prevalence rates exist. Certain populations show higher frequencies, ranging from one in 2,000 among some Mediterranean groups to one in 100,000 in Sweden. These differences reflect genetic isolation in specific communities over many generations.
Diagnosing Cystinuria
The most definitive analysis is with infrared or X-ray diffraction, which is a non-invasive method of testing for the presence of stones. Chemical stone analysis provides another diagnostic tool when stones are available for testing. The presence of pure cystine stones confirms the diagnosis, though mixed compositions may require additional evaluation.
Microscopic examination of fresh urine can reveal characteristic hexagonal crystals that appear yellowish-brown. These crystals help confirm the condition when they are found, but not finding them doesn’t rule it out.
Quantitative testing via 24-hour urine collection measures total cystine excretion. Normal individuals excrete less than 30 milligrams daily, while affected people typically exceed 400 milligrams. The cyanide-nitroprusside test detects elevated cystine levels in spot urine samples and serves as a useful initial screening test.
Treatment Options
High fluid intake forms the cornerstone of management. Affected individuals must consume enough liquid to produce at least three liters of urine daily, which typically requires drinking four to five liters throughout each day, including nighttime consumption.
Alkalinizing the urine significantly increases cystine solubility. Potassium citrate is the preferred agent, with target urine pH levels maintained between 7.0 and 7.5. Dietary modifications include reducing animal protein intake, limiting sodium consumption, and avoiding methionine-rich foods.
When conservative measures prove insufficient, thiol-based medications like tiopronin or penicillamine become necessary. These drugs bind to cystine molecules to form more soluble compounds, but they also carry significant side effects that require careful monitoring.
Surgical intervention is necessary when stones cause obstruction or grow too large to pass. Options include shock wave lithotripsy, ureteroscopy, and percutaneous procedures for larger stones.
Living With and After Cystinuria
Cystinuria requires lifelong management that significantly impacts daily routines. Most people need ongoing dietary restrictions, medication regimens, and frequent medical follow-up visits to monitor treatment effectiveness and watch for complications.
Maintaining treatment adherence presents considerable challenges due to extensive lifestyle modifications. High fluid intake throughout each day can disrupt sleep patterns and daily activities. Many individuals struggle with frequent urination and the constant need to locate restrooms.
Some people experience medication side effects, particularly with thiol-based drugs that may cause nausea, skin reactions, and taste alterations. Long-term kidney function monitoring becomes increasingly important with age. Regular blood tests, urine studies, and imaging help detect complications early and guide treatment adjustments.
When to Seek Medical Care
Severe back or side pain suggesting kidney stones requires prompt medical evaluation, particularly when accompanied by nausea or vomiting. Emergency care may be necessary for pain control and to rule out complete obstruction, which can cause permanent kidney damage.
Blood in the urine warrants medical attention as it may indicate stone movement or urinary tract injury. Any visible discoloration should prompt same-day evaluation, while microscopic blood requires follow-up within several days.
Family members of individuals diagnosed with a condition should consider screening evaluations, particularly those planning pregnancies. Fever accompanying urinary symptoms represents a serious complication requiring immediate antibiotic treatment.
Changes in urination patterns, persistent pain between episodes, or recurring infections should prompt evaluation even in individuals with well-controlled disease. These symptoms may indicate treatment failure or complications requiring modifications.